Impact of Routine Hepatitis B Immunization on the Prevalence of Chronic Hepatitis B Virus Infection in the Marshall Islands and the Federated States of Micronesia

Background: To evaluate the impact of routine hepatitis B (HB) vaccination on the prevalence of chronic hepatitis B virus (HBV) infection among children in Pacific Island countries where HBV infection was highly endemic, we conducted HB serosurveys during 2000 to 2007 among women of childbearing age born before implementation of HB vaccination and among children born after its implementation. Methods: Serum specimens were collected from children aged 2 to 6 years and their mothers in Chuuk, Federated States of Micronesia in 2000, children aged 2 to 9 years and their mothers in Pohnpei, Federated States of Micronesia in 2005, and 5- to 9-year-old children and prenatal clinic patients in 2007 in Republic of the Marshall Islands (RMI). Specimens were tested for HB surface antigen (HBsAg) and antibodies to HB core antigen (total anti-HBc). HB vaccination coverage was determined from health department vaccination registries. We defined chronic HBV infection as the presence of HBsAg. Results: Birthdose and 3 dose HB vaccination coverage was 48% and 87%, respectively, in Chuuk, 87% and 90% in Pohnpei, and 49% and 93% in RMI. Chronic HBV infection prevalence among children was 2.5% (9/362) in Chuuk, 1.5% (7/478) in Pohnpei and 1.8% (6/331) in RMI. Chronic HBV infection prevalence among women was 9.2% (21/229) in Chuuk, 4.4% (10/229) in Pohnpei, and 9.5% (11/116) in RMI. Conclusions: Hepatitis B vaccination has resulted in a substantial decline in chronic infection in children in the Pacific Islands. HB vaccine effectiveness is high in this region, despite challenges in providing HB vaccine at birth and completing vaccination series on schedule.

[1]  R. Leggiadro.  Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) – United States, May–August 2009 , 2010 .

[2]  N. Van Cuong,et al.  Implementation of and costs associated with providing a birth-dose of hepatitis B vaccine in Viet Nam. , 2008, Vaccine.

[3]  A. Sutanto,et al.  Implementing the birth dose of hepatitis B vaccine in rural Indonesia. , 2007, Vaccine.

[4]  T. Vogt,et al.  Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  B. Biggs,et al.  Improving birth dose coverage of hepatitis B vaccine. , 2006, Bulletin of the World Health Organization.

[6]  H. Margolis,et al.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7]  D. Kelly,et al.  Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. , 2004, The Journal of infectious diseases.

[8]  Y. Buisson,et al.  10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia). , 2003, Vaccine.

[9]  H. Margolis,et al.  Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination , 2003, The Pediatric infectious disease journal.

[10]  W. Lim,et al.  The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothers , 2003, Journal of viral hepatitis.

[11]  K. Wong,et al.  The implication of a reduced-dose hepatitis B vaccination schedule in low risk newborns. , 2002, Vaccine.

[12]  N. Wilson,et al.  The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. , 2000, Vaccine.

[13]  L. Hwang,et al.  Hepatitis B vaccination in high-risk infants: 10-year follow-up. , 1999, The Journal of infectious diseases.

[14]  M. Lai,et al.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.

[15]  Withers Bg,et al.  Vaccine-preventable disease susceptibility in a young adult Micronesian population. , 1994 .

[16]  P. Kelley,et al.  Vaccine-preventable disease susceptibility in a young adult Micronesian population. , 1994, Southeast Asian Journal of Tropical Medicine and Public Health.

[17]  F. Mahoney,et al.  Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. , 1993, The Journal of infectious diseases.

[18]  S. J. Manea,et al.  The hepatitis B immunization campaign for children in the Federated States of Micronesia. , 1992, Public health reports.

[19]  J. Roux,et al.  Prevalence of hepatitis B virus infection in the Austral archipelago, French Polynesia: identification of transmission patterns for the formulation of immunization strategies. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  A. Hill,et al.  HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey , 1988, Epidemiology and Infection.

[21]  R H Purcell,et al.  Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific. , 1979, American journal of epidemiology.

[22]  P. Zimmet,et al.  Seroepidemiology of infection with hepatitis A and B viruses in an isolated Pacific population. , 1979, The Journal of infectious diseases.

[23]  V. Nam.  Viet Nam , 1976, Revue Internationale de la Croix-Rouge.